Tannic acid-induced apoptosis and -enhanced sensitivity to arsenic trioxide in human leukemia HL-60 cells

Leukemia Research

Volumn 33, Issue 2, 2009, Pages 297-307

  Chen, Kuo Shuen ^a   Hsiao, Yung Chin ^a   Kuo, Dong Yih ^a   Chou, Ming Chih ^a   Chu, Shu Chen ^b   Hsieh, Yih Shou ^a   Lin, Tseng Hsi ^a,c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Acute myeloid leukemia cells; Apoptosis; SOD; Superoxide; Tannic acid

Indexed keywords

ARSENIC TRIOXIDE; CASPASE; CYTOCHROME C; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TANNIN;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CHROMOSOME CONDENSATION; CONTROLLED STUDY; CYTOTOXICITY; DIPLOIDY; DNA FRAGMENTATION; DOWN REGULATION; DRUG INHIBITION; DRUG POTENTIATION; DRUG SENSITIVITY; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION;

APOPTOSIS; ARSENICALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HL-60 CELLS; HUMANS; KINETICS; LEUKEMIA, MYELOID, ACUTE; MITOCHONDRIA; OXIDES; SUPEROXIDE DISMUTASE; TANNINS;

EID: 56949083197     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.08.006     Document Type: Article

References (42)

1. Roboz G.J. Treatment of acute myeloid leukemia in older patients. Expert Rev Anticancer Ther 7 (2007) 285-295
2. Tallman M.S., Gilliland D.G., and Rowe J.M. Drug therapy for acute myeloid leukemia. Blood 106 (2005) 1154-1163
3. Jabbour E.J., Estey E., and Kantarjian H.M. Adult acute myeloid leukemia. Mayo Clin Proc 81 (2006) 247-260
4. Bachleitner-Hofmann T., Kees M., and Gisslinger H. Arsenic trioxide: acute promyelocytic leukemia and beyond. Leuk Lymphoma 43 (2002) 1535-1540
5. Miller Jr. W.H., Schipper H.M., Lee J.S., Singer J., and Waxman S. Mechanisms of action of arsenic trioxide. Cancer Res 62 (2002) 3893-3903
6. Berenson J.R., and Yeh H.S. Arsenic compounds in the treatment of multiple myeloma: a new role for a historical remedy. Clin Lymphoma Myeloma 7 (2006) 192-198
7. Jing Y., Dai J., Chalmers-Redman R.M., Tatton W.G., and Waxman S. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 94 (1999) 2102-2111
8. Ratnaike R.N. Acute and chronic arsenic toxicity. Postgrad Med J 79 (2003) 391-396
9. D'Alessandro N., Poma P., and Montalto G. Multifactorial nature of hepatocellular carcinoma drug resistance: could plant polyphenols be helpful?. World J Gastroenterol 13 (2007) 2037-2043
10. Rudolf E., Andelova H., and Cervinka M. Polyphenolic compounds in chemoprevention of colon cancer-targets and signaling pathways. Anticancer Agents Med Chem 7 (2007) 559-575
11. Stevenson D.E., and Hurst R.D. Polyphenolic phytochemicals-just antioxidants or much more?. Cell Mol Life Sci 64 (2007) 2900-2916
12. Fresco P., Borges F., Diniz C., and Marques M.P. New insights on the anticancer properties of dietary polyphenols. Med Res Rev 26 (2006) 747-766
13. Romani A., Ieri F., Turchetti B., Mulinacci N., Vincieri F.F., and Buzzini P. Analysis of condensed and hydrolysable tannins from commercial plant extracts. J Pharm Biomed Anal 41 (2006) 415-420
14. Gali-Muhtasib H.U., Yamout S.Z., and Sidani M.M. Tannins protect against skin tumor promotion induced by ultraviolet-B radiation in hairless mice. Nutr Cancer 37 (2000) 73-77
15. Nepka C., Sivridis E., Antonoglou O., Kortsaris A., Georgellis A., Taitzoglou I., et al. Chemopreventive activity of very low dose dietary tannic acid administration in hepatoma bearing C3H male mice. Cancer Lett 141 (1999) 57-62
16. Koide T., Kamei H., Hashimoto Y., Kojima T., and Hasegawa M. Tannic acid raises survival rate of mice bearing syngeneic tumors. Cancer Biother Radiopharm 14 (1999) 231-234
17. Nam S., Smith D.M., and Dou Q.P. Tannic acid potently inhibits tumor cell proteasome activity, increases p27 and Bax expression, and induces G1 arrest and apoptosis. Cancer Epidemiol Biomarkers Prev 10 (2001) 1083-1088
18. Sakagami H., Jiang Y., Kusama K., Atsumi T., Ueha T., Toguchi M., et al. Cytotoxic activity of hydrolyzable tannins against human oral tumor cell lines-a possible mechanism. Phytomedicine 7 (2000) 39-47
19. Hsiao Y.C., Hsieh Y.S., Kuo W.H., Chiou H.L., Yang S.F., Chiang W.L., et al. The tumor-growth inhibitory activity of flavanone and 2′-OH flavanone in vitro and in vivo through induction of cell cycle arrest and suppression of cyclins and CDKs. J Biomed Sci 14 (2007) 107-119
20. Ho Y.S., Duh J.S., Jeng J.H., Wang Y.J., Liang Y.C., Lin C.H., et al. Griseofulvin potentiates antitumorigenesis effects of nocodazole through induction of apoptosis and G2/M cell cycle arrest in human colorectal cancer cells. Int J Cancer 91 (2001) 393-401
21. Douglas R.S., Tarshis A.D., Pletcher Jr. C.H., Nowell P.C., and Moore J.S. A simplified method for the coordinate examination of apoptosis and surface phenotype of murine lymphocytes. J Immunol Methods 188 (1995) 219-228
22. Chen P.N., Chu S.C., Chiou H.L., Chiang C.L., Yang S.F., and Hsieh Y.S. Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell growth and induce apoptosis in vitro and suppress tumor growth in vivo. Nutr Cancer 53 (2005) 232-243
23. Shen S.C., Ko C.H., Tseng S.W., Tsai S.H., and Chen Y.C. Structurally related antitumor effects of flavanones in vitro and in vivo: involvement of caspase 3 activation, p21 gene expression, and reactive oxygen species production. Toxicol Appl Pharmacol 197 (2004) 84-95
24. Mantena S.K., Sharma S.D., and Katiyar S.K. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther 5 (2006) 296-308
25. Wang L., Chanvorachote P., Toledo D., Stehlik C., Mercer R.R., Castranova V., et al. Peroxide is a key mediator of Bcl-2 down-regulation and apoptosis induction by cisplatin in human lung cancer cells. Mol Pharmacol 73 (2008) 119-127
26. Yun Y.S., and Lee Y.N. Production of superoxide dismutase by Deinococcus radiophilus. J Biochem Mol Biol 36 (2003) 282-287
27. Kucuk O. Cancer chemoprevention. Cancer Metastasis Rev 21 (2002) 189-197
28. Weisburger J.H. Practical approaches to chemoprevention of cancer. Drug Metab Rev 26 (1994) 253-260
29. Yang C.S., Landau J.M., Huang M.T., and Newmark H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21 (2001) 381-406
30. Kurata R., Adachi M., Yamakawa O., and Yoshimoto M. Growth suppression of human cancer cells by polyphenolics from sweetpotato (Ipomoea batatas L.) leaves. J Agric Food Chem 55 (2007) 185-190
31. Gali H.U., Perchellet E.M., Klish D.S., Johnson J.M., and Perchellet J.P. Hydrolyzable tannins: potent inhibitors of hydroperoxide production and tumor promotion in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate in vivo. Int J Cancer 51 (1992) 425-432
32. Sroka Z., Rzadkowska-Bodalska H., and Mazol I. Antioxidative effect of extracts from Erodium cicutarium L. Z Naturforsch [C] 49 (1994) 881-884
33. Labieniec M., and Gabryelak T. Effects of tannins on Chinese hamster cell line B14. Mutat Res 539 (2003) 127-135
34. Bhat R., and Hadi S.M. DNA breakage by tannic acid and Cu(II): generation of active oxygen species and biological activity of the reaction. Mutat Res 313 (1994) 49-55
35. +, common signals for apoptosis induced by gallic acid. Biochem Pharmacol 55 (1998) 1973-1981
36. Mertens-Talcott S.U., and Percival S.S. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett 218 (2005) 141-151
37. Remacle J., Raes M., Toussaint O., Renard P., and Rao G. Low levels of reactive oxygen species as modulators of cell function. Mutat Res 316 (1995) 103-122
38. Xiang N., Zhao R., and Zhong W. Sodium selenite induces apoptosis by generation of superoxide via the mitochondrial-dependent pathway in human prostate cancer cells. Cancer Chemother Pharmacol (2008)
39. Cho S.J., Park J.W., Kang J.S., Kim W.H., Juhnn Y.S., Lee J.S., et al. Nuclear factor-kappaB dependency of doxorubicin sensitivity in gastric cancer cells is determined by manganese superoxide dismutase expression. Cancer Sci (2008)
40. Yedjou C.G., Rogers C., Brown E., and Tchounwou P.B. Differential effect of ascorbic acid and n-acetyl-l-cysteine on arsenic trioxide-mediated oxidative stress in human leukemia (HL-60) cells. J Biochem Mol Toxicol 22 (2008) 85-92
41. Park J.H., Kim E.J., Jang H.Y., Shim H., Lee K.K., Jo H.J., et al. Combination treatment with arsenic trioxide and sulindac enhances apoptotic cell death in lung cancer cells via activation of oxidative stress and mitogen-activated protein kinases. Oncol Rep 20 (2008) 379-384
42. Baumgartner M., Sturlan S., Roth E., Wessner B., and Bachleitner-Hofmann T. Enhancement of arsenic trioxide-mediated apoptosis using docosahexaenoic acid in arsenic trioxide-resistant solid tumor cells. Int J Cancer 112 (2004) 707-712